X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7770) 7770
Publication (414) 414
Book Review (338) 338
Book Chapter (10) 10
Conference Proceeding (6) 6
Dissertation (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7157) 7157
butyrates - pharmacology (4697) 4697
animals (4180) 4180
humans (3466) 3466
male (1575) 1575
rats (1555) 1555
butyric acid (1420) 1420
mice (1272) 1272
sodium-butyrate (1141) 1141
female (1120) 1120
butyrate (1023) 1023
biochemistry & molecular biology (1021) 1021
cell line (950) 950
oncology (799) 799
butyrates - metabolism (716) 716
pharmacology & pharmacy (708) 708
apoptosis (697) 697
expression (690) 690
cell differentiation - drug effects (660) 660
cells, cultured (656) 656
histone deacetylase inhibitors (647) 647
cell biology (636) 636
kinetics (634) 634
tumor cells, cultured (632) 632
sodium butyrate (606) 606
chain fatty-acids (561) 561
dose-response relationship, drug (561) 561
apoptosis - drug effects (547) 547
cell division - drug effects (538) 538
differentiation (538) 538
time factors (526) 526
butyrates (499) 499
acetylation (489) 489
enzyme inhibitors - pharmacology (478) 478
cell line, tumor (475) 475
in vitro techniques (472) 472
esters (468) 468
histones - metabolism (436) 436
gene-expression (434) 434
cyclic amp - pharmacology (431) 431
gene expression (417) 417
cancer (410) 410
research (386) 386
hydroxamic acids - pharmacology (363) 363
proteins (359) 359
cells (352) 352
abridged index medicus (350) 350
fatty acids (348) 348
hydrogen-ion concentration (330) 330
analysis (310) 310
rna, messenger - metabolism (308) 308
growth (300) 300
induction (300) 300
metabolism (300) 300
activation (297) 297
fermentation (285) 285
histone deacetylase inhibitors - pharmacology (284) 284
antineoplastic agents - pharmacology (282) 282
gene expression regulation - drug effects (279) 279
propionates - pharmacology (272) 272
in-vitro (271) 271
physiological aspects (267) 267
nutrition & dietetics (265) 265
butyric acid - pharmacology (261) 261
histone deacetylase (260) 260
drug synergism (259) 259
biotechnology & applied microbiology (258) 258
cell proliferation - drug effects (258) 258
cell survival - drug effects (255) 255
neurosciences (253) 253
diet (248) 248
rats, sprague-dawley (248) 248
cell differentiation (245) 245
dietary fiber (241) 241
blotting, western (240) 240
cell cycle - drug effects (237) 237
adult (236) 236
transfection (236) 236
butyrates - chemistry (235) 235
sodium (235) 235
structure-activity relationship (234) 234
physiology (232) 232
colon (230) 230
histone deacetylases - metabolism (228) 228
microbiology (226) 226
rna, messenger - genetics (223) 223
multidisciplinary sciences (220) 220
inflammation (217) 217
colonic neoplasms - pathology (216) 216
immunology (215) 215
proliferation (212) 212
article (211) 211
cell cycle (211) 211
gastroenterology & hepatology (211) 211
colon - metabolism (207) 207
stimulation, chemical (206) 206
acetates - pharmacology (203) 203
inhibition (203) 203
liver - drug effects (203) 203
liver - metabolism (202) 202
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7381) 7381
French (79) 79
German (76) 76
Russian (67) 67
Italian (53) 53
Chinese (52) 52
Japanese (42) 42
Polish (7) 7
Spanish (7) 7
Czech (3) 3
Portuguese (3) 3
Ukrainian (2) 2
Hebrew (1) 1
Korean (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Physiology - Regulatory Integrative and Comparative Physiology, ISSN 0363-6119, 01/2013, Volume 304, Issue 1, pp. R23 - R32
The interaction between adenosine and soluble epoxide hydrolase (sEH) in vascular response is not known. Therefore, we hypothesized that lack of sEH in mice... 
Relaxation | CYP2J5-epoxgenase;ω-hydroxylase | receptor | Soluble epoxide hydrolase | Contraction | Adenosine A | Epoxide Hydrolases - physiology | Adenosine-5'-(N-ethylcarboxamide) - pharmacology | Butyrates - pharmacology | Male | Receptor, Adenosine A2A - physiology | Lauric Acids - pharmacology | Vasodilation - genetics | 8,11,14-Eicosatrienoic Acid - analogs & derivatives | Adenosine A2 Receptor Agonists - pharmacology | Urea - analogs & derivatives | Female | Benzamides - pharmacology | Oxygenases - physiology | Vasodilation - physiology | 8,11,14-Eicosatrienoic Acid - pharmacology | Adamantane - analogs & derivatives | NG-Nitroarginine Methyl Ester - pharmacology | Adamantane - pharmacology | Triazines - pharmacology | Phenethylamines - pharmacology | Vasodilator Agents - pharmacology | Enzyme Inhibitors - pharmacology | Gene Silencing | Adenosine - pharmacology | Pyrimidines - pharmacology | Epoxide Hydrolases - genetics | Triazoles - pharmacology | Adenosine A2 Receptor Antagonists - pharmacology | PPAR gamma - physiology | Animals | Adenosine - analogs & derivatives | Benzoates - pharmacology | Mice | Phenylurea Compounds - pharmacology | Pyridines - pharmacology | Vasodilation - drug effects | Urea - pharmacology | Index Medicus | adenosine A2a receptor | CYP2J5-epoxgenase | ω-hydroxylase | relaxation | contraction | Cardiovascular and Renal Integration | soluble epoxide hydrolase | adenosine A1 receptor
Journal Article
Life Sciences, ISSN 0024-3205, 2003, Volume 73, Issue 4, pp. 471 - 485
Antinociceptive profiles of decursinol were examined in ICR mice. Decursinol administered orally (from 5 to 200 mg/kg) showed an antinociceptive effect in a... 
Serotonin receptor | α 2 adrenoceptor | Antinociception | Decursinol | Histamine receptor | Adenosine receptor | Inflammatory pain | adrenoceptor | MEDICINE, RESEARCH & EXPERIMENTAL | antinociception | histamine receptor | MORPHINE | ADENOSINE | STIMULI | SPINAL-CORD | RECEPTOR | serotonin receptor | RESPONSES | alpha adrenoceptor | PAIN | adenosine receptor | inflammatory pain | PHARMACOLOGY & PHARMACY | MICE | FORMALIN TEST | SUBSTANCE-P | decursinol | Analgesics - pharmacology | Models, Chemical | Histamine H2 Antagonists - pharmacology | Butyrates - pharmacology | Male | Substance P - pharmacology | Adrenergic alpha-Antagonists - pharmacology | Methysergide - pharmacology | Xanthines - pharmacology | Yohimbine - pharmacology | Dose-Response Relationship, Drug | Theobromine - analogs & derivatives | Cyproheptadine - pharmacology | Piperidines - pharmacology | Pain - drug therapy | Butyrates - administration & dosage | Theobromine - pharmacology | Benzopyrans - pharmacology | Ranitidine - pharmacology | Glutamic Acid - pharmacology | Administration, Oral | Receptors, Adrenergic - metabolism | Protein Kinase C - antagonists & inhibitors | Serotonin Antagonists - pharmacology | Mice, Inbred ICR | Receptors, Serotonin - metabolism | Interleukin-1 - pharmacology | Tumor Necrosis Factor-alpha - pharmacology | Benzopyrans - administration & dosage | Receptors, Histamine - metabolism | Animals | Naloxone - pharmacology | Narcotic Antagonists - pharmacology | Mice | Receptors, Purinergic P1 - metabolism | Interferon-gamma - pharmacology | Index Medicus
Journal Article
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 2009, Volume 616, Issue 1, pp. 73 - 80
Harmaline-induced tremor in rodents is a model of essential tremor. We utilized a novel assay to quantify tremor activity in mice and found that tremor... 
Harmaline | Dopamine | Gabapentin | Primidone | Lithium | Glutamate | Carbamazepine | Valproate | Validity | D 1 receptor | GABA | Propranolol | Essential tremor | ICR mouse | D 2 receptor | γ-Hydroxy-butyrate | receptor | GAMMA-HYDROXYBUTYRIC ACID | NUCLEUS-ACCUMBENS DOPAMINE | D-2 receptor | SUBUNIT MESSENGER-RNAS | AMINO-ACIDS | SODIUM-VALPROATE | PHARMACOLOGY & PHARMACY | gamma-Hydroxy-butyrate | AMINOBUTYRIC-ACID | RECEPTOR SUBUNITS | NEUROTRANSMITTER RELEASE | INFERIOR OLIVE | D-1 receptor | DRUG-INDUCED TREMOR | Receptors, Glutamate - metabolism | Muscimol - pharmacology | gamma-Aminobutyric Acid - metabolism | Glutamates - metabolism | Male | Anticonvulsants - pharmacology | Dose-Response Relationship, Drug | Propranolol - pharmacology | Lithium Chloride - pharmacology | Neurotransmitter Agents - pharmacology | Tremor - chemically induced | Behavior, Animal - drug effects | Raclopride - pharmacology | Chlordiazepoxide - pharmacology | Dopamine - metabolism | Baclofen - pharmacology | Harmaline - pharmacology | Affect - drug effects | Benzazepines - pharmacology | Piperazines - pharmacology | Mice, Inbred ICR | Sodium Oxybate - pharmacology | Animals | Mice | Carbolines - pharmacology | Propranolol hydrochloride | Methyl aspartate | Pyridine | Analysis | Gamma-hydroxybutyrate | Chemical properties | Barbiturates | Index Medicus
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 03/2016, Volume 75, Issue 3, pp. 593 - 600
Journal Article
Naunyn-Schmiedeberg's Archives of Pharmacology, ISSN 0028-1298, 4/2009, Volume 379, Issue 4, pp. 325 - 336
The aim of this study was to investigate the putative influence of some pharmacological agents and drugs of abuse upon the apical uptake of butyrate (BT) into... 
Neurosciences | Biomedicine | Caco-2 cells | Modulation | Pharmacology/Toxicology | Uptake | Butyrate | ULCERATIVE-COLITIS | TISSUE HOMEOSTASIS | COLONIC MONOCARBOXYLATE TRANSPORTER | EPITHELIAL-CELLS | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | CHAIN FATTY-ACIDS | COLORECTAL-CANCER | TUMOR-SUPPRESSOR | PHARMACOLOGY & PHARMACY | RAT DISTAL COLON | DIETARY BIOACTIVE COMPOUNDS | Butyrates - metabolism | Gene Expression - drug effects | Gene Expression - genetics | Humans | Ions - pharmacology | Monocarboxylic Acid Transporters - antagonists & inhibitors | N-Methyl-3,4-methylenedioxyamphetamine - pharmacology | Symporters - antagonists & inhibitors | Caffeine - pharmacology | Acetaldehyde - pharmacology | Aspirin - pharmacology | Dronabinol - pharmacology | Acids, Acyclic - pharmacology | Caco-2 Cells | Cell Survival - drug effects | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid - pharmacology | Biological Transport, Active - drug effects | Indomethacin - pharmacology | Symporters - genetics | 2,4-Dinitrophenol - pharmacology | 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid - pharmacology | Theophylline - pharmacology | Kinetics | Monocarboxylic Acid Transporters - genetics | Sodium Azide - pharmacology | Hydrogen-Ion Concentration | Lactates | Messenger RNA | Analysis | Ecstasy (Drug) | Illegal drugs | Esters | Universities and colleges | Nonsteroidal anti-inflammatory drugs | Theophylline | Acetaldehyde | Caffeine | Index Medicus
Journal Article
Oncology Reports, ISSN 1021-335X, 2/2014, Volume 31, Issue 2, pp. 955 - 968
Histone deacetylase inhibitors and bisphosphonates have a promising future in the treatment of cancer as targeted anticancer drugs, particularly when used... 
adjuvant therapy | Ewing sarcoma | sodium butyrate | chemotherapy | zoledronic acid | synergistic effect | Zoledronic acid | Sodium butyrate | Chemotherapy | Synergistic effect | Adjuvant therapy | CELLS | COMBINATION | FAMILY | BISPHOSPHONATES | ONCOLOGY | OSTEOSARCOMA | BONE | HISTONE DEACETYLASE INHIBITORS | TUMOR-GROWTH | Cell Survival - drug effects | Tumor Stem Cell Assay | Vincristine - pharmacology | Antibiotics, Antineoplastic - pharmacology | Humans | Etoposide - pharmacology | Imidazoles - pharmacology | Molecular Targeted Therapy | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Bone Density Conservation Agents - pharmacology | Sarcoma, Ewing - drug therapy | Drug Synergism | Cell Line, Tumor | Histamine Antagonists - pharmacology | Histone Deacetylase Inhibitors - pharmacology | Butyric Acid - pharmacology | Cell Proliferation - drug effects | Antineoplastic Agents, Phytogenic - pharmacology | Diphosphonates - pharmacology | Doxorubicin - pharmacology | Pharmacology, Experimental | Enzyme inhibitors | Diphosphonates | Oncology, Experimental | Research | Drug therapy | Health aspects | Ewing's sarcoma | Drug synergism | Cancer | Medical research | Genes | Cytotoxicity | Cancer therapies | Proteins | Acids | Sodium | Medical prognosis | Cell cycle | Epigenetics | Drug dosages | Tumors | Apoptosis | Index Medicus
Journal Article
Oncogene, ISSN 0950-9232, 06/2001, Volume 20, Issue 26, pp. 3387 - 3398
The molecular basis for the sensitivity of tumor cells to chemopreventive natural food compounds and commonly used chemotherapeutic agents is not well... 
Chemotherapy | Colon cancer | p21 | Butyrate | p53 | P53-INDUCED APOPTOSIS | butyrate | colon cancer | NITRIC-OXIDE SYNTHASE | ANTICANCER AGENTS | BIOCHEMISTRY & MOLECULAR BIOLOGY | DNA-DAMAGE | CYCLE ARREST | HUMAN CANCER-CELLS | chemotherapy | CELL BIOLOGY | ONCOLOGY | GROWTH ARREST | CHAIN FATTY-ACIDS | DIETARY FIBER | GENETICS & HEREDITY | Adenocarcinoma - pathology | Intracellular Membranes - physiology | Apoptosis - drug effects | Butyrates - pharmacology | Humans | Neoplasm Proteins - physiology | Drug Resistance, Neoplasm | Stilbenes - pharmacology | Toluene - analogs & derivatives | Tumor Suppressor Protein p53 - physiology | Genes, p53 | Amino Acid Chloromethyl Ketones - pharmacology | Recombination, Genetic | Antineoplastic Agents - pharmacology | Cyclins - physiology | Gene Expression Regulation, Neoplastic - drug effects | Toluene - pharmacology | Anticarcinogenic Agents - pharmacology | Membrane Potentials - drug effects | Cyclin-Dependent Kinase Inhibitor p21 | Demecolcine - pharmacology | Tumor Cells, Cultured - drug effects | Etoposide - pharmacology | Cisplatin - pharmacology | Mitochondria - drug effects | Colonic Neoplasms - pathology | Cysteine Proteinase Inhibitors - pharmacology | Alleles | Fluorouracil - pharmacology | Intracellular Membranes - drug effects | Thiazoles - pharmacology | Apoptosis - physiology | Doxorubicin - pharmacology | Benzothiazoles | Anthracyclines | Carcinoma | Membrane potentials | Etoposide | Mitochondrial DNA | Fatty acids | Prevention | Resveratrol | Physiological aspects | Tumor proteins | Health aspects | Cancer | Apoptosis | Index Medicus
Journal Article
Journal Article
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 06/2007, Volume 321, Issue 3, pp. 892 - 901
Journal Article
Cellular Microbiology, ISSN 1462-5814, 07/2017, Volume 19, Issue 7, pp. e12720 - n/a
Journal Article